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Protein kinase C (PKC) play critical roles in many
cellular functions including differentiation, prolifera-
tion, growth, and survival. However, the molecular
bases governing PKC’s substrate recognitions
remain poorly understood. Here we determined the
structure of PKCi in complex with a peptide from
Par-3 at 2.4 A˚. PKCi in the complex adopts catalyti-
cally competent, closed conformation without phos-
phorylation of Thr402 in the activation loop. The
Par-3 peptide binds to an elongated groove formed
by the N- and C-lobes of the kinase domain. The
PKCi/Par-3 complex structure, together with exten-
sive biochemical studies, reveals a set of substrate
recognition sites common to all PKC isozymes as
well as a hydrophobic pocket unique to aPKC. A
consensus aPKC’s substrate recognition sequence
pattern can be readily identified based on the
complex structure. Finally, we demonstrate that the
pseudosubstrate sequence of PKCi resembles its
substrate sequence, directly binds to and inhibits
the activity of the kinase.
INTRODUCTION
Protein kinase C (PKC) family of serine/threonine kinases plays
essential roles in multiple signaling pathways and cellular
processes including early development, tumor formation and
progression, immune responses, and cell polarity regulation
(Henrique and Schweisguth, 2003; Kalive et al., 2010; Martiny-
Baron and Fabbro, 2007; Tan and Parker, 2003; Webb et al.,
2000). Every PKC isozyme contains N-terminal regulatory
regions and a C-terminal kinase domain. Based on their struc-
tures and regulatory mechanism, PKCs can be divided into
conventional, novel and atypical subfamilies (cPKC, nPKC, and
aPKC, respectively). Each cPKC (a, b1, b2, and g) contains two
diacylglycerol-binding C1 domains (C1A and C1B) followed by
a Ca2+- and phosphoinositol lipid-binding C2 domain in their
N-terminal regulatory domains. Members of nPKCs (d, q, h, ε)Structure 20have the same domain compositions in their regulatory region
as cPKCs do, except that the C2 domain of each nPKCs is
located N-terminal to the two C1 domains, and the C2 domains
of nPKCs do not bind to Ca2+ (Ponting and Parker, 1996). In
contrast to the cPKCs and nPKCs, aPKC isozymes (z and l/i)
do not contain C2 domain. Instead, each aPKC contains a PB1
domain at the very N-terminus followed by an atypical C1
domain that does not bind to DAG (Suzuki et al., 2003). Addition-
ally, all PKCs contain a pseudosubstrate sequence in their
N-terminal regulatory domains, which maintains kinases in their
inactive state in the absence of activation signals (House and
Kemp, 1987; Newton, 1997). Members of both the cPKCs and
nPKC families require second messengers (DAG and/or Ca2+)
for their activations (Webb et al., 2000). In contrast, PKCz and
PKCi require neither Ca2+ nor DAG for their activation, and hence
they are termed as atypical PKCs. PKCz and PKCi share very
high amino acid sequence identity. Compared to PKCz, PKCi
is ubiquitously expressed in all tissues (Fields and Regala,
2007). Themajority of studies on aPKC described in the literature
are on PKCi. Despite of their critical roles in many biological
processes including asymmetric cell division, cell polarity estab-
lishment and maintenance, cell migration, and tumor formation
(Etienne-Manneville and Hall, 2003; Fields and Regala, 2007;
Prehoda, 2009), the activation mechanisms of PKCz and PKCi
are poorly understood.
Besides being regulated by the secondary messengers via the
N-terminal regulatory domains, PKCs are also regulated through
phosphorylation of Ser/Thr residues in the activation loop, the
turn-, and the hydrophobic-motifs in their C-terminal regulatory
segments (Newton, 2003). The activation loop of PKC isoforms
has been shown to be phosphorylated by PDK1 and this phos-
phorylation primes PKCs for further autophosphorylation and
activation (Behn-Krappa and Newton, 1999; Le Good et al.,
1998). For atypical PKCs, the phosphorylation site in the hydro-
phobic motif is replaced by a glutamic acid, which presumably
mimics the corresponding phosphor-Ser/Thr in other PKCs.
Previously reported aPKC kinase structures were obtained
with both the activation loop and turn-motif Ser/Thr phosphory-
lated (Messerschmidt et al., 2005; Takimura et al., 2010).
However, it has been shown that phosphorylation of the Thr
residue in the activation loop is not required for PKCz’s kinase
activity (Ranganathan et al., 2007). Consistent with this finding
and to the best of our knowledge, it has not been reported, 791–801, May 9, 2012 ª2012 Elsevier Ltd All rights reserved 791
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The aPKCi/Par-3 Complex Structurethat, at least in the Par-3/Par-6/aPKC-mediated cell polarity
regulations, aPKC requires another upstream kinase for its acti-
vation. Again, it is unclear why aPKCs do not require activation
loop phosphorylation for their activation.
In line with the remarkable range of biological functions regu-
lated by PKCs, numerous proteins, such as GSK3b, MARCKS,
LGN, Par-3, Lgl, Crumb, etc., are known as direct substrates
of the kinases (Betschinger et al., 2003; Goode et al., 1992;
Hao et al., 2010; Herget et al., 1995; Nagai-Tamai et al., 2002;
Sotillos et al., 2004). Not matched with the extensive functional
and biochemical studies of PKC-mediated phosphorylation of
target proteins, no structure has been reported for any member
of PKCs in complex with a substrate protein/peptide to date;
although the structures of the kinase domains of a number of
PKC isoforms as well as the full-length PKCbII have been solved
(Grodsky et al., 2006; Leonard et al., 2011; Messerschmidt et al.,
2005; Takimura et al., 2010; Wagner et al., 2009; Xu et al., 2004).
Our current understandings of the substrate specificity of PKC
isozymes are largely derived from an oriented peptide library
study nearly 15 years ago (Nishikawa et al., 1997). High resolu-
tion atomic structures of PKCs in complex with their cognate
substrates will be highly valuable to enhance our knowledge of
the substrate recognition mechanisms of different isoforms of
PKCs.
Here we present the structure of the PKCi kinase domain in
complex with a substrate peptide derived from Par-3, which,
to our knowledge, represents the first substrate-bound structure
of the entire PKC family kinases. The structure of the PKCi/Par-3
peptide complex reveals that the kinase domain adopts an
active conformation even though Thr402 in the activation loop
is not phosphorylated. The Par-3 peptide binds to the groove
between the N- and C-lobes of the kinase via combined hydro-
phobic and charge-charge interactions. The structure of the
complex, along with detailed amino acid sequence analysis
and extensive biochemical studies, allowed us to derive
a consensus and specific substrate sequence for aPKC. The
data presented in this study can also serve as a template in
understanding substrate specificities of other members of PKC
isozymes.
RESULTS
aPKCi Binds and Phosphorylates a Short Peptide
Fragment of Par-3
Previous studies reported that Par-3 can be phosphorylated by
aPKC. The aPKC phosphorylation site is located within amino
acid residues 712–936, and the region is thus referred to as the
aPKC binding domain of Par-3 (Morais-de-Sa´ et al., 2010;
Nagai-Tamai et al., 2002). To characterize the aPKC/Par-3 inter-
action in detail, we mapped the minimal aPKC binding domain of
Par-3 using bacterially purified GST-fused Par-3 fragments to
pull down GFP-PKCi kinase domain (aa 222–586 of mouse
PKCi) expressed in HEK293 cells (Figure 1). This mapping exper-
iment revealed that a 28-residue fragment of Par-3 (aa 813–840)
is sufficient to bind to the kinase domain of PKCi (Figure 1A).
Correspondingly, any Par-3 sequences containing this
28-residue peptide fragment can be robustly phosphorylated
by the purified GFP-PKCi kinase domain (Figure 1B). This
minimal PKCi-binding sequence of Par-3 contains 2 Ser resi-792 Structure 20, 791–801, May 9, 2012 ª2012 Elsevier Ltd All rightsdues (Ser827 and Ser829) that are completely conserved from
worm to mammals (Figures 1C and 1E). Substitution of Ser829
with Ala has minimal impact on its phosphorylation by PKCi. In
contrast, substitution of Ser827 with Ala largely eliminated its
PKCi-mediated phosphorylation (Figure 1B, lane 4), indicating
that Ser827 is the main PKCi phosphorylation site of the Par-3
fragment. Replacements of both Ser827&829with Ala eliminated
PKCi-mediated phosphorylation of the Par-3 fragment (Fig-
ure 1B). Only background level of phosphorylation could be de-
tected for the longest Par-3 fragment (aa 712–854) when
a kinase-dead mutant of PKCi, in which the catalytic Lys273
was replaced by Arg (K273R-PKCi), was used for the phosphor-
ylation assay (Figure 1B, last lane), indicating that the phosphor-
ylation of the Par-3 fragments shown in Figure 1B are specifically
catalyzed by PKCi.
We found that substitution of Ser827 with Glu essentially abol-
ished Par-3’s binding to PKCi (Figure 1D), indicating that phos-
phorylation promotes substrate dissociation from the kinase.
This result provides a mechanistic explanation to well-docu-
mented findings showing that aPKC-mediated phosphorylation
of Par-3 (or Bazooka in Drosophila) promotes Par-3’s dissocia-
tion from the Par-6/aPKC complex at the apical membranes of
polarized epithelia (Morais-de-Sa´ et al., 2010; Nagai-Tamai
et al., 2002). The substitution of Ser827 with Ala also weakened
the Par-3 fragment’s binding to PKCi, suggesting that the side
chain of Ser827 also plays a positive role in the kinase binding.
In contrast, substitution of Ser829 with Ala has no detectable
impact on Par-3’s binding to PKCi. It is noted that substitution
of Ser829 with Glu also eliminated Par-3’s binding to PKCi
(Figure 1D), although it is not clear what does this mean at the
current stage.
Overall Structure of the PKCi/Par-3 Peptide Complex
To elucidate how PKCi binds to Par-3, we determined the crystal
structure of the K273R-PKCi kinase domain in complex with
the 28-residue Par-3 peptide (813DPVLAFQREGFGRQSMSE
KRTKQFSNAS840) and an ATP analog AMP-PCP (referred to
as the PKCi/Par-3 complex from hereafter) at 2.4 A˚ resolution
(Table 1). The Lys273 to Arg mutation should inactivate the
kinase activity of PKCi with minimal structural perturbations.
Except for a few negatively charged residues in the loop con-
necting aB and aC (282DDED285 to be specific) and a short frag-
ment proceeding aG (449SDNPDQ454), the entire kinase domain
is well resolved in the refined model of the PKCi/Par-3 complex
(Figure 2A). The kinase domain is composed of an N-lobe,
a C-lobe, and a regulatory segment composed of a turn-motif
and a hydrophobic motif at the C-terminal tail, which turns
back from the C-lobe and wraps around the N-lobe. Thr554 in
the turn motif of the regulatory segment is phosphorylated (Fig-
ure 2A). In the crystal, only the adenosine ring of AMP-PCP is
defined (Figure 2A). The overall structure of the PKCi kinase
domain determined here is highly similar to the human PKCi
kinase domain either in complex with ATP or an ATP analog-
based inhibitor (Messerschmidt et al., 2005; Takimura et al.,
2010), thus we will not discuss the structural features that are
shared by these three structures in any details further. A unique
exception found in the PKCi/Par-3 complex is that Thr402 in the
activation loop of the kinase is not phosphorylated, and yet the
conformation of the loop is well-defined (Figures 2A and 3;reserved
Figure 1. PKCi Binds to and Phosphorylates a 28-Residue Peptide Fragment of Par-3
(A) Mapping of the minimal PKCi binding region of Par-3. Purified GST-fused Par-3 fragments were used to pull-down GFP-PKCi kinase domain expressed in
HEK293T cells. GST-Par-3 proteins were stained by Coomassie blue, and GFP-PKCi was detected with anti-GFP antibody.
(B) Purified PKCi kinase domain specifically phosphorylates Ser827 of Par-3 in 32P-autoradiography-based assays. The kinase-dead mutant, K273R-PKCi, is
used as the negative control of the experiment.
(C) Schematic diagram showing the domain organizations of Par-3 as well as the various Par-3 fragments used in (A).
(D) Phospho-mimetic substitution of Ser827 with Glu abolishes Par-3’s binding to PKCi.
(E) Alignment of the 27-residue, PKCi binding sequence of Par-3 from different species. The two serine residues in these sequences are colored in red, the fully
conserved residues are colored in blue, and highly conserved residues are highlighted in cyan.
Structure
The aPKCi/Par-3 Complex StructureFigures S3A and S3B available online). A total of 16 residues of
the Par-3 peptide (814PVLAFQREGFGRQSMS829) are clearly
defined (Figures 2A and 4A). The Par-3 peptide binds to the pre-
dicted substrate binding groove formed by the N- and C-lobe of
the kinase in a rather twisted conformation due to the formation
of two turn-like structures (Figure 2A, see Figure 4 and related
discussions below).
PKCi Kinase Domain Adopts a Closed Conformation
in the Complex
Based on the relative positions of the N-lobe to the C-lobe, the
overall conformation of a kinase can be classified as either the
open state or the closed state, each representing different steps
in its catalytic cycle (Taylor and Kornev, 2011). In its open state,
a kinase can recruit ATP to its N-lobe for another cycle of cata-
lytic reaction. Whereas in the closed state, the ‘‘closure’’ of theStructure 20N- and C-lobes positions ATP as well as the catalytic amino
acids in a geometry suitable for transferring g-phosphate from
ATP to its substrate (Johnson et al., 2001). We superimposed
the C-lobes of PKCi structure from this study with that of the
open state PKCi structure (Protein Data Bank [PDB] code:
3A8W) determined earlier (Takimura et al., 2010), and found
that the N-lobes of the two structures have an root-mean-square
deviation (rmsd) value of 3.45 A˚ (Figure 2B). In contrast, the
rmsd value of only 1.24 A˚ was found for the N-lobes when
the C-lobe of the PKCi structure from this study was superim-
posed with that of the closed state of PKCq (PDB code: 1XJD)
(Figure 2B). This structural analysis indicates the PKCi kinase
domain in complex with Par-3 adopts a closed conformation
(Figure 2B). A rigid body rotation of the N-lobe by15 clockwise
would convert aPKC from the open- to the closed-conformation
(Figure 2B). In the open state, the g-phosphate of ATP would be, 791–801, May 9, 2012 ª2012 Elsevier Ltd All rights reserved 793
Table 1. Statistics of Data Collection and Model Refinement of
the PKCi/Par-3 Peptide Complex
Data Collection
Data sets PKCi /Par-3
Source SSRF-BL17U
Space group C2
Unit cell parameters (A˚,) a = 101.5, b = 54.9, c = 82.5,
b = 115.2
Resolution range (A˚)a 50.00–2.40 (2.44–2.40)
No. of unique reflectionsa 14,458 (726)
Redundancya 2.9 (2.8)
I/sa 11.4 (1.68)




Resolution (A˚)a 21.2–2.40 (2.59–2.40)
Rcryst/Rfree (%)
a,c,d 17.2 (21.4)/24.1(29.9)











Most favored regions (%) 96.4
Additionally allowed (%) 3.3
Outliers (%) 0.3
Rmsd, root-mean-square deviation.
aNumbers in parentheses represent the value for the high resolution shell.
bRmerge = SUM (ABS(I <I>))/SUM (I), where I is the intensity of measured
reflection and <I> is the mean intensity of all symmetry-related reflec-
tions.
cRcryst = SjFcalc – Fobsj/SFobs, where Fobs and Fcalc are observed and
calculated structure factors.
dRfree =STjFcalc – Fobsj/SFobs, where T is a test data set of5%of the total
unique reflections randomly chosen and set aside prior to refinement.
eRefinement is processed with phenix.refinement, and B-factor values
are extracted by phenix validation tools.
Structure
The aPKCi/Par-3 Complex Structurefar away from Asn373 (5.2 A˚) and Lys370 (6.1 A˚) in the cata-
lytic loop, and from Ser827 (7.1 A˚ to the phosphate-accepting
oxygen atom) of the Par-3 peptide (Figures S2A and S2B).
Closure of the N-lobe positions the ATP g-phosphate at the cata-
lytically competent position both with respect to the catalytic
residues from the kinase and the phosphate accepting Ser827
of Par-3 (Figures S2C and S2D). Taken together, the structure
of the PKCi/Par-3 complex determined in this study reveals
that the kinase domain is in its catalytically competent, closed
conformation.
PKCi Is Active without the Activation Loop
Phosphorylation
ABC kinases together with other kinases such as PKG all belong
to the so called AGC kinases family as they share considerable794 Structure 20, 791–801, May 9, 2012 ª2012 Elsevier Ltd All rightssimilarities in their kinase domains (Pearce et al., 2010). Activa-
tion of AGC kinases generally requires phosphorylation of three
Ser/Thr residues: one from the activation loop and two from
the C-terminal regulatory segment composed of a turn motif
and a hydrophobic motif. The phosphorylation of the turn motif
and the hydrophobic motif anchors the regulatory segment to
the N-lobe, which is critical for keeping the two lobes of the
kinases in their active conformations (Pearce et al., 2010). In
the PKCi/Par-3 complex, Thr554 in the turn motif is phosphory-
lated. Glu573 in the hydrophobic motif and phosphor-Thr554 in
the turn motif function together to stabilize the interaction
between the C-terminal regulatory segment and the N-lobe of
the kinase domain (Figure S3D).
Phosphorylation of the activation loop shapes the substrate
binding site and/or modulates the phosphate transfer step
during catalysis, and is known as a general activation mecha-
nism in the majority of protein kinases (Adams, 2003). In the
PKCi/Par-3 complex, the entire activation loop is clearly defined
and Thr402 in the activation loop is not phosphorylated (Figures
S3A, S3B, and 2A). Although Thr402 is not phosphorylated, the
conformation of the activation loop of PKCi in our structure (in
yellow) is essentially identical to that of PKCi crystalized with
Thr402 phosphorylated (in orange) (Messerschmidt et al., 2005)
except for the several polar interactions induced by the phos-
phate group (Figure 3B). The formation of this well-defined acti-
vation loop conformation in the absence of Thr402 phosphoryla-
tion is the result of extensive hydrogen bonding networks,
charge-charge interactions, and hydrophobic contacts between
the residues from the activation loop and amino acids from both
lobes of the kinase (Figure 3). The conserved ‘‘DFG’’-motif
(‘‘386DYG388’’ in PKCi) (Figure 3A) and the ‘‘P+1’’-pocket (Fig-
ure 3C) of the kinase domain also actively participate in the stabi-
lization of the activation loop conformation. It is interesting to
note that the hydrophobic residue corresponding to Phe422 in
PKCi, which is in close contact with Leu394 and thus expected
to play a positive role in stabilizing the activation loop conforma-
tion, is conserved only in aPKCs and PKCd (Figure S1). In line
with this observation, both aPKC and PKCd have been reported
to be catalytically active even when their activation loops are not
phosphorylated (Stempka et al., 1997; Ranganathan et al.,
2007). Our structural data indicate that the interaction between
Par-3 and the kinase domain of PKCi does not require the phos-
phorylation of Thr402. Our structure-based analysis further
suggests that activation of aPKCsmay not require the phosphor-
ylation of Thr in their activation loops.
Finally, the conformation of PKCi in the complex with Par-3
contains two prominent structural hallmarks known for many
protein kinases in their active states, namely the formation of
two spatially continuous hydrophobic interaction networks
called the R-spine (regulatory spine) and the C-spine (catalytic
spine) (see Figure S3E for details) (Kornev et al., 2008; Taylor
and Kornev, 2011). The R-spine and the C-spine are linked by
the gatekeeper Ile322 (the orange sphere, Figure S3E middle).
Residues forming both the R-spine and the C-spine of PKCi
are aligned well with the active forms of AGC kinases including
ATP-bound apo-PKCi (PDB code: 3A8W), PKB in complex with
a GSK peptide (PDB code: 1O6L), and PKCq (PDB code: 1XJD)
(Figure 3D). In contrast, the inactive PKB kinase domain (PDB
code: 1GZN) has amisaligned R-spine and C-spine (Figure S3E).reserved
Figure 2. PKCi Adopts an Active and Closed Conformation in Complex with the Par-3 Peptide
(A) Ribbon diagram showing the overall structure of the PKCi/Par-3 complex. The ATP analog, AMPPCP, is shown in sphere and colored in cyan. Thr554 in the
regulatory segment is phosphorylated and drawn in the stick model. The unphosphorylated Thr402 in the activation loop is also shown with the stick model. The
2Fo-Fc electron density of the unphosphorylated Thr402 in the activation loop contoured at 0.9s is shownwith meshed surface, colored in blue. The bound Par-3
peptide is shown with the worm model in scarlet red.
(B) Comparison of the overall kinase domain structure of PKCi from the PKCi/Par-3 complex with that of an open state PKCi (PDB code: 3A8W), and that of
a closed state PKCq (PDB code: 1XJD). In the comparison, the C-lobe of the kinase domains are superimposed with each other, and the positions of the N-lobes
are compared. The cartoons below show the relative position of the N-lobe, C-lobe, substrate, and ATP in both the open and closed states of the kinases.
See also Figures S2 and S3.
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The aPKCi/Par-3 Complex StructureThe Kinase and Par-3 Peptide Interface
The Par-3 peptide occupies the groove between the N- and
C-lobes of the kinase (Figure 4A). The kinase-bound peptide is
twisted due to the formation of two continuous turn-like struc-
tures, which are facilitated by the presence of two Gly residues
(Gly822 and Gly824) in the peptide (Figures 4B and 4C). The
binding of the Par-3 peptide to PKCi is rather extensive, covering
965 A˚2 of surface area. Both polar (charge-charge and hydrogen
bonding) and hydrophobic interactions contribute to the kinase/
substrate binding (Figures 4B and 4C). Detailed analysis of the
complex structure identifies three discrete hydrophobic interac-
tions sites (referred to as the c-site-1, -2, and -3) and three
charge-charge interaction sites (referred to as the charge site-
1, -2, and -3) that are critical for binding to the Par-3 peptide
(Figures 4B and 4C).
The c-site-1 is formed by the side chains of Met331, Met334
from aD, and Leu371 proceeding b7, and this site accommo-
dates Phe818 at the 9 position of the Par-3 peptide. Ile445
and Val446 from the unique insertion between aF and aG found
in aPKCs, and Leu460 from aG form the c-site-2, which func-
tions as the binding site for Phe823 at the 4 position of the
Par-3 peptide. The c-site-3 is formed by Phe403, Pro407,
Ile410 from the P+1 loop, and Phe461 from aG, and this hydro-
phobic pocket accepts Met828 at the +1 position of the Par-3
peptide (Figures 4B and 4C).Structure 20The charge site-1 contains Asp329 N-terminal to aD,
Asp372 before b7, and Asp543 before the turn-motif. Arg820
at the 7 position of the Par-3 peptide forms salt-bridges
with the three negatively charged residues in the charge
site-1. Asp435 from aF acts as the principle residue in the
charge site-2 and forms a salt bridge with Arg825 at the 2
position of the Par-3 peptide. Additionally, the side chain of
Arg825 forms several hydrogen bonds with side chains of
Asn408 and Tyr409 from the P+1 loop of the kinase. The
charge site-3 is rather tentative. We notice from the structure
of the PKCi/Par-3 complex that a stretch of positively charge
residues (e.g., Lys831 and Arg832 at the +4 and +5 positions
that are not well-defined in the structure) of the Par-3 peptide
are in close vicinity of a negatively charge cassette
(‘‘282DDED285’’) proceeding aC of the kinase (Figures 4C and
S1). We hypothesize that the ‘‘282DDED285’’-cassette forms
the charge site-3 of the kinase, and this charge site interacts
with Lys831 and Arg832 from the Par-3 peptide. Indeed, either
mutation of K831 or R832 in the Par-3 peptide with Ala (Fig-
ure 4D) or substitution of ‘‘282DDED285’’ with ‘‘KLKQ’’ (the cor-
responding sequence in PKA, Figure S1) in the kinase domain
largely decreased the binding between PKCi and the Par-3
peptide (Figure 4E). Further consistent with the above struc-
tural analysis, substitutions of Phe818, Arg820, Phe823, or
Arg825 of the Par-3 peptide individually with Ala either, 791–801, May 9, 2012 ª2012 Elsevier Ltd All rights reserved 795
Figure 3. PKCi in the PKCi/Par-3 Complex Is Active without the Need of Its Activation Loop Phosphorylation
(A) The interactions with the ‘‘DFG’’-loop of the kinase domain (colored in cyan) that helps to orientate the activation loop. The hydrogen bond between Y387 and
the backbone of V306 is unique for aPKC isozymes (Figure S1).
(B) The superimposed structural comparison of the unphosphorylated activation loop of PKCi (in yellow) in the PKCi/Par-3 complex with that of the phos-
phorylated activation loop of PKCi (colored in orange). Numerous interactions that stabilize the unphosphorylated activation loop of PKCi. Expect for the polar
interactions between the phosphate group and R367, K391, and T400, the rest of the interactions are retained in the unphosphorylated activation loop of the
kinase.
(C) The interactions in ‘‘P+1’’ loop (colored in cyan) that helps to stabilize the activation loop. Two hydrogen bonding networks formed by N408-E435-Y409 and
K370-T406-D368, together with the hydrophobic interactions formed by F403, I410, L415, and F461 in the ‘‘P+1’’ loop stabilize the conformation of the activation
loop.
See also Figure S3.
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The aPKCi/Par-3 Complex Structureabolished or largely weakened the peptide’s binding to PKCi
(Figure 4D). As a control, substitution of Gln826, whose side
chain points to the opposite direction of the binding interface,
with Ala had no effect on the peptide’s binding to the kinase
(Figure 4D).
A Consensus Sequence Pattern of aPKC Substrates
To further understand substrate specificities of aPKCs, we
aligned the kinase domain sequences of ABC kinases (PKA,
PKB, and PKC), and mapped the sequence conservation profile
of the ABC kinases onto the PKCi structure determined in this
work (Figure 5A). This sequence conservation map reveals the
following features for the substrate binding surfaces of the
ABC family kinases: the entire ABC family kinases share similar
substrate binding surfaces; the surface similarity of the PKC
subfamily is even greater; and finally, the substrate binding
surfaces among aPKCs are completely conserved. With this
finding, we predicted that we should be able to identify
a consensus substrate recognition pattern for aPKCs based
on the structure of the PKCi/Par-3 complex and other previ-
ously identified aPKC substrates including Numb (Smith et al.,
2007), Lgl (Betschinger et al., 2003), and Crb3 (Sotillos et al.,
2004).
Figure 5B is the amino acid sequence alignment of the Par-3
peptide with predicted aPKC’s substrate peptides from Numb,
Lgl, and Crb3. The alignment is first based on the Ser residues
at the 0 position, and then aided by the two positively charged
residues (Arg820 and Arg825 in Par-3) binding to the charge
site-1 and -2 and the two hydrophobic residues (Phe818 and
Phe823 in Par-3) binding to the c-site-1 and -2 of PKCi shown796 Structure 20, 791–801, May 9, 2012 ª2012 Elsevier Ltd All rightsin Figure 4. Based on this alignment analysis, a highly
consensus aPKC’s substrate recognition sequence pattern
emerges as:
c X01  R=K X02  c A=G0 101  R=K X S=Tð0Þ
 c X13R=K R=K;
where ‘‘c’’ represents hydrophobic residues, and ‘‘X’’ denotes
any residue but preferably polar amino acids. The presence
of a Gly at the 3 position of the Par-3 peptide allows the
formation of the Turn-2. Without this Gly, the Arg and the hydro-
phobic residue (Arg2 and Phe4 of the Par-3) can assume
similar position if the backbone of the segment adopts an
extended structure. Similarly, the positively charged residue in
the 7 position of the Par-3 peptide (Arg820) is likely to be
able to occupy a similar position even with the removal of
Gly5 and/or Glu6 in Par-3, which forms the Turn-1 (Figures
5A and 5B). The above analysis provides an explanation to
the variable gaps in the aPKC’s substrate sequences shown
in Figure 5B.
The structure and the sequence conservation map show that
aPKCs contain a unique insertion with seven to nine amino acid
residues (Figures 5A and S1). In our structure, the hydrophobic
residues in this insert are well-defined and form the c-site-2 that
binds to Phe823 at the 4 position of the Par-3 peptide. We
predicted that this aPKC unique insertion is likely to play
a role in the substrate specificities of the kinases. To test this,
we deleted the 9-residue insertion (‘‘IVGSSDNPD,’’ Figure S1)
from PKCi, and the mutant kinase lost its binding capacity toreserved
Figure 4. The Interaction Surface between PKCi and the Par-3 Peptide
(A) The omit map of the Par-3 peptide in the PKCi/Par-3 structure. The kinase N-lobe and C-lobe are colored in green and gray, respectively. The Par-3 peptide is
colored in yellow. The Fo-Fc density map is shown in blue and contoured at 3s.
(B) Stereo-view of the PKCi/the Par-3 peptide interface. The backbone of the Par-3 peptide and its side chains interacting with PKCi are shown in purple. The
hydrophobic and charged residues from PKCi, which are involved in the interaction with Par-3, are drawn in yellow and cyan, respectively.
(C) The combined surface (PKCi) and stick (Par-3) representations of the PKCi/the Par-3 peptide interface. The positively charged residues of PKCi are drawn in
blue, the negatively charged residues in red, the hydrophobic residues in yellow and the others in gray. The residues C-terminal to Ser829 of the Par-3 peptide and
the 282DDED285 -segment of PKCi could not be seen in our crystal structure. The 282DDED285 -segment in this drawing is modeled onto the PKCi structure based
on the structure of PKCi in complex with an inhibitor (PDB code: 3A8X). The three hydrophobic sites and the three charged sites, which are key contacting sites
with the Par-3 peptide, are indicated.
(D) Mutational analysis of the roles of selected residues from the Par-3 peptide in binding to PKCi.
(E) Substitution of the 282DDED285-segment in PKCi with the corresponding sequence from PKA (‘‘KLQK’’) largely decreases its binding to Par-3.
See also Figure S1.
Structure
The aPKCi/Par-3 Complex Structurethe Par-3 peptide (Figure 5C). Additionally, at the edge of the
c-site-2 of aPKC is a strictly conserved Asn (Asn408 in PKCi).
The corresponding residue in other ABC kinases including
cPKC and nPKC is a negatively charged Asp/Glu (Figure S1).
It is predicted that the presence of a negatively charged residue
instead of Asn408 would hinder the hydrophobic interaction
between Phe823 of Par-3 and the c-site-2 of the kinase (Fig-
ure 5A). Indeed, substitution of Asn408 with Asp weakened
PKCi’s binding to Par-3 (Figure 5C). Similarly, removal of the
turn-2 of Par-3 (821EGFG824) essentially eliminated Par-3’s
binding to PKCi (Figure 5D, top row). We tested this Par-3 dele-
tion mutant in its possible binding to Drosophila eye-PKC,
which is a member of cPKC. It was found that this Par-3 mutant
displayed a slightly enhanced binding to eye-PKC when
compared to the WT Par-3 (Figure 5D, bottom row), as if the
mutation had converted the Par-3 peptide to be a better
cPKC substrate.Structure 20Pseudosubstrate of aPKC Regulates Substrate Binding
and Phosphorylation
The PKC family kinases are known to possess a pseudosub-
strate (PS) right before the C1 domain. The PS sequences of
PKCs resemble their substrate sequences but has an Ala
residue at the 0 position instead of a Ser/Thr (Pearce et al.,
2010). The predicted PS of PKCi is located immediately
N-terminal to the C1 domain, and aligns well with the Par-3
peptide (Figure 6A). The difference between PS and the Par-3
peptide is that PS does not have a hydrophobic residue that
is equivalent to Phe823 of the Par-3 peptide, thus this PS binds
to the kinase domain of PKCi with a weaker affinity than the
Par-3 peptide does (Figure 6B). Nonetheless, because PS
binding to the kinase domain in the full-length PKCi is an intra-
molecular interaction, the binding is expected to be consider-
ably stronger than the intermolecular interaction shown in
Figure 6B., 791–801, May 9, 2012 ª2012 Elsevier Ltd All rights reserved 797
Figure 5. A Consensus Substrate Recognition Motif of aPKCs
(A) The amino acid conservation map of the residues in the substrate binding grooves of ABC kinases including PKA, PKB, and PKC isozymes drawn on the
surface of the PKCi structure. Residues that are totally conserved in all ABC kinases are shown in green, those conserved only in the PKC subfamily are shown in
light green, the aPKC-specific residues are shown in blue, and nonconserved residues are in gray. A stretch of five residues in the unique aPKC insert (‘‘SDNPD’’)
that are not defined in the crystal structure is indicated and connected with a dashed line.
(B) Structural based sequence alignment of reported aPKC’s substrates. The positions of residues N- and C-terminal to the phosphorylation site Ser/Thr are
indicated at the bottom of the alignment. The consensus sequence motif derived from the alignment is also included at the bottom of the alignment. The
interaction sites of the consensus residues on the kinase domain are indicated below the alignment.
(C) Deletion of the aPKC specific insertion residue forming the c-site-2 disrupts PKCi’s binding to Par-3. Substitution of Asn408 in the c-site-2 with Asp also
weakens PKCi’s binding to Par-3.
(D) Removal of 821EGFG824 from the Par-3 reduces its binding to PKCi. In contrast, removal of 821EGFG824 from the Par-3 slightly increased its binding to
Drosophila eye-PKC.
See also Figure S1.
Structure
The aPKCi/Par-3 Complex StructureWe tested the functional role of PS in the kinase activity regu-
lation by substituting its ‘‘YRR’’-cassette with triple Ala residues
(Figure 6A). Although not as strong as the kinase domain only of
PKCi does, the ‘‘YRR/AAA’’ mutant of the full length kinase dis-
played a considerably stronger binding to the Par-3 peptide than
the wild-type full length enzyme (Figure 6C), indicating that the
autoinhibition of the kinase is largely relived in the mutant. We
further demonstrate that the ‘‘YRR/AAA’’ mutant of the full length
PKCi displayed a higher kinase activity than the wild-type kinase
in phosphorylating Par-3 (Figure 6D), further supporting that the798 Structure 20, 791–801, May 9, 2012 ª2012 Elsevier Ltd All rightsPS sequence indeed inhibits the kinase activity of PKCi by block-
ing the accessibility of kinase’s real substrates. Finally, amino
acid sequence analysis of other members of the PKC subfamily
kinases reveals that all PKCs contain similar pseudosubstrate
motifs (Figure 6E).
DISCUSSION
The PKCi/Par-3 complex structure solved in this work repre-
sents, to our knowledge, the first substrate-bound form structurereserved
Figure 6. The Pseudosubstrate Sequence Binds to and Inhibits the Kinase Activity of PKCi
(A) Schematic diagram showing the domain organization and the sequence of the pseudosubstrate of PKCi.
(B) The pseudosubstrate (PS) of PKCi binds to the kinase domain with a lower affinity than that of the Par-3 peptide does. Mutations of the ‘‘YRR’’-cassette at the
4 to 2 position of PS with triple Ala eliminates the binding between the kinase domain and PS of PKCi. Note that the blot in this panel is the same as the one
shown in the top panel of Figure 5D.
(C) PS inhibits the binding between PKCi and Par-3. The Par-3 peptide shows a much weaker binding affinity to the full-length PKCi than to the kinase domain of
PKCi. Release of the auto-inhibition with the ‘‘YRR/AAA’’-mutation enhances PKCi’s binding to Par-3.
(D) The PS inhibits the kinase activity of PKCi. Release of the autoinhibition with the ‘‘YRR/AAA’’-mutation enhances PKCi’s kinase activity in phosphorylating
Par-3.
(E) Structure-based sequence alignment of the PS sequences in PKC isozymes.
(F) A schematic diagram summarizing the substrate binding modes of the ABC family kinases. The figure depicts that the ABC family kinases share overlapping
substrate recognition patterns. However, the presence of specific hydrophobic binding pockets for recognizing bulky hydrophobic residues upstream of
Ser/Ter(0) distinguishes aPKCs from other kinases.
See also Figure S1.
Structure
The aPKCi/Par-3 Complex Structureof the PKC family isozymes. In the complex, PKCi adopts
a closed, catalytically competent conformation. The PKCi/Par-3
complex structure also reveals that neither the Par-3 substrate
peptide binding nor the formation of the active conformation
seems to require phosphorylation of Thr402 in the activation
loop of the kinase. The extensive interactions of the residues
from the activation loop with both lobes of the kinase domain
are sufficient to define the conformation of the activation loop.
Phosphorylation of Thr402 does not induce significant confor-
mational changes of the activation loop or the kinase domain
of PKCi as a whole (Figure 3B). The PKCi/Par-3 complex struc-
ture also reveals that Leu394 in the activation loop interacts
extensively with Phe422 at the beginning of aF of the kinase
domain (Figure 3B). The presence a Phe at the first residue of
aF is unique to aPKCs and PKCd. The corresponding residue
in the rest of ABC family kinases either a positively charged
residue or Pro (Figure S1). This structure- and sequence-based
analysis nicely explains why aPKC and PKCd do not require
the activation loop phosphorylation for their kinase activities
(Stempka et al., 1997; Ranganathan et al., 2007). The findingStructure 20that aPKCs do not require their activation loop for their kinase
activities has important functional implications. For example,
unlike other members of PKC isozymes, activities of aPKCs do
not require them to be primed by other kinases such as PDK1.
Instead, regulated spatial localizations of aPKCs are known to
be critically important for their cellular functions (Betschinger
et al., 2003; Smith et al., 2007). Consistent with this notion, func-
tions of aPKC in numerous Par-3/Par-6/aPKC-mediated cellular
processes are not known to require another upstream kinase to
phosphorylate its activation loop.
The atomic structure of the PKCi/Par-3 complex, together
with previously solved structures of various ABC family kinases
(Yang et al., 2002; Zheng et al., 1993) allows us to better define
their substrate specificities. The surface conservation map of
the substrate binding groove of the ABC family kinases clearly
shows that all these kinases share a common set of substrate
binding pockets including two charge sites (charge sites 1 and 2)
(Figure 5A). Therefore, the ABC family kinases share certain
common features in the sequences of their substrates. For
example, all prefer to have two positively charged amino acids, 791–801, May 9, 2012 ª2012 Elsevier Ltd All rights reserved 799
Structure
The aPKCi/Par-3 Complex StructureN-terminal to the phosphorylation site (Figure 6F). The similari-
ties of the substrate binding grooves among PKC subfamily
isozymes are even higher (Figure 5A), therefore their substrates
overlapping is also expected to be higher, as they all contains
an extra charge site 3. Nonetheless, aPKCs contain a unique
hydrophobic site (c-site-2, Figures 4C and 5A), which is absent
in cPKCs and nPKCs. Thus, aPKCs prefer substrates with an
additional bulky hydrophobic residue sandwiched by two




Mouse Anti-GFP antibody was purchased from Santa Cruz; mouse anti-flag
antibody M2 was from Sigma-Aldrich.
GST Pull-Down Assay
HEK293T cells transiently transfected with various GFP-PKCi or flag-PKCi
encoding plasmids were harvested at 18 hr posttransfection. Collected cells
were lysed using the lysis buffer (50 mM HEPES, 150 mM NaCl, 100 mM
NaF, 1% Triton X-100, 10% glycerol, 1.5 mM MgCl2, 1 mM EGTA, 1 mM
DTT, 0.5 mM PMSF, 10 mM PNPP, 20 mM b-glycerolphosphate, 50 mM
sodium vanadate, and a cocktail of protease inhibitors from Calbiochem). In
each binding reaction, 0.15 nmol of purified GST-fused Par-3 protein and
100 ml GFP-PKCi-containing cell lysates were mixed in 900 ml PBS. The
mixture was incubated at 4C for 30 min before being centrifuged at
14,000 3 g for 5 min. The supernatant was mixed with 25 ml of fresh GSH-
coupled Sepharose 4B slurry beads and themixture was incubated for another
30 min. After two times washing with the wash buffer (with 0.1% Triton X100,
otherwise same as the lysis buffer), the proteins captured by the GSH-Sephar-
ose beads were boiled and resolved with SDS-PAGE. GFP-PKCi or flag-PKCi
captured by GST-Par-3 was immunodetected using corresponding antibody.
Protein Expression and Purification
The kinase dead kinase domain of mouse PKCi (aa 222–586 with Lys273
substituted Arg; GenBank accession code: BC021630.1) was cloned into
the pFastBac HTB vector (from Invitrogen) using the EcoRI single restriction
digestion site. The recombinant virus was obtained by transposition and trans-
fection following the Bac-to-Bac expression system’s user manual and serial
amplified by infecting sf-9 cells of increasing volumes. For expression,
300 ml of sf-9 cells (1 3 106 cells per mL) was infected by virus with multi-
plicity of infection value of 10, and cells were collected by centrifugation at
400 3 g after 72 hr incubation at 27C. Collected cells were resuspended in
the Ni2+-NTA affinity column binding buffer (5 mM imidazole, 500 mM NaCl,
50 mM Tris, 2 mM b-mercaptoethanol, pH 8.5) with a cocktail of protease
inhibitors from Calbiochem and then lysed by sonication. The soluble portion
of the cell lysate was obtained by centrifugation at 30,0003 g and loaded onto
a Ni2+-NTA affinity column. After 30 min incubation, the column was washed
extensively with the wash buffer (the column buffer plus 30 mM imidazole).
The captured, His-tagged PKCiwas eluted with 6ml elution buffer (the column
buffer plus 1M imidazole) and further purified by another step of size exclusion
chromatography (S200 column from GE Healthcare) in the final buffer (50 mM
Tris, 100 mM NaCl, 1 mM DTT, and 1 mM EDTA, pH 8.0).
In Vitro Kinase Assay
HEK293T cells transfected with the flag-tagged wide type or mutant PKCi
kinase domain was lysed using the lysis buffer. Approximately 100 ml cell lysate
was mixed with 400 ml PBS, 1 mg M2 anti-flag antibody, and 25 ml protein G
beads slurry. The mixture was incubated at 4C for 2 hr. The protein G
beads-captured PKCi was washed twice with the lysis buffer and then once
with the kinase assay buffer (20 mM MOPS, 100 mM NaCl, 15 mM MgCl2,
100 mM ATP, pH 7.2). The antibody-captured PKCi was released by the addi-
tion of the flag peptide to a final concentration of 0.1 mg/ml. In each kinase
reaction assay, 20 mg GST-Par-3 was mixed with PKCi in 50 ml of the kinase
assay buffer containing 0.2 mCi [g-P32]-ATP, and the reaction was allowed to800 Structure 20, 791–801, May 9, 2012 ª2012 Elsevier Ltd All rightsproceed for 30 min at room temperature before being terminated with boiling.
The proteins in the reaction mixtures were separated by SDS-PAGE. The SDS-
PAGE gel was dried and the phosphorylated GST-Par-3 proteins were de-
tected by autoradiography.
Crystallization, Data Collection, and Processing
Crystals of the K273R-PKCi kinase domain in complex with the Par-3 peptide
were obtained by the hanging drop vapor diffusionmethod at 16C. The freshly
purified protein at a concentration of 8 mg/ml was mixed with 5 mM MgCl2,
200 mM AMPPCP, and five times molar ratio of the Par-3 peptide. The PKCi/
Par-3 complex crystals were grown in 3.5 M sodium formate, pH7.0. The
crystal was quickly frozen by dipping into liquid nitrogen. X-ray data were
collected at the beam-line BL17U1 of the Shanghai Synchrotron Radiation
Facility. The diffraction data were processed and scaled by HKL2000 (Otwi-
nowski and Minor, 1997).
Using the structure of the aPKC kinase domain (PDB id: 1ZRZ) as the search
model, the initial structural model was solve using the molecular replacement
method in PHASER (McCoy et al., 2007). The model was then refined by the
phenix.refinement (Adams et al., 2010). COOT (Emsley and Cowtan, 2004)
was used for peptide modeling and model adjustments. TLS refinement was
applied at the final refinement stage. The final structure was validated by phe-
nix.model_vs_data validation tool (Adams et al., 2010). The structure figures
were prepared using the program PyMOL (http://pymol.sourceforge.net/).
ACCESSION NUMBERS
The atomic coordinates of PKCi/Par-3 complex structure have been depos-
ited to the Protein Data Bank under the accession code 4DC2.
SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures and can be found with this
article online at doi:10.1016/j.str.2012.02.022.
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